PetMed Express, Inc.
PETS
$3.40
-$0.09-2.58%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 194.99M | 208.67M | 223.70M | 236.77M | 249.10M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 194.99M | 208.67M | 223.70M | 236.77M | 249.10M |
| Cost of Revenue | 134.32M | 141.64M | 152.04M | 159.75M | 169.11M |
| Gross Profit | 60.67M | 67.03M | 71.67M | 77.02M | 79.99M |
| SG&A Expenses | 80.80M | 79.76M | 73.46M | 68.24M | 73.66M |
| Depreciation & Amortization | 8.22M | 7.60M | 7.04M | 6.86M | 7.04M |
| Other Operating Expenses | -1.18M | -1.18M | -1.18M | -1.09M | -1.09M |
| Total Operating Expenses | 222.16M | 227.83M | 231.36M | 233.77M | 248.73M |
| Operating Income | -27.17M | -19.15M | -7.66M | 3.00M | 378.00K |
| Income Before Tax | -48.88M | -39.44M | -587.00K | 1.92M | -488.00K |
| Income Tax Expenses | 6.15M | 4.74M | 5.68M | 1.56M | 475.00K |
| Earnings from Continuing Operations | -55.02 | -44.18 | -6.27 | 0.36 | -0.96 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -55.02M | -44.18M | -6.27M | 357.00K | -963.00K |
| EBIT | -27.17M | -19.15M | -7.66M | 3.00M | 378.00K |
| EBITDA | -18.95M | -11.55M | -618.00K | 8.86M | 6.42M |
| EPS Basic | -2.65 | -2.13 | -0.30 | 0.02 | -0.05 |
| Normalized Basic EPS | -0.82 | -0.56 | -0.20 | 0.13 | 0.06 |
| EPS Diluted | -2.66 | -2.14 | -0.31 | 0.01 | -0.06 |
| Normalized Diluted EPS | -0.82 | -0.56 | -0.21 | 0.13 | 0.05 |
| Average Basic Shares Outstanding | 82.92M | 82.63M | 82.38M | 82.19M | 81.98M |
| Average Diluted Shares Outstanding | 82.92M | 82.97M | 83.15M | 82.96M | 82.75M |
| Dividend Per Share | -- | -- | -- | 0.00 | 0.00 |
| Payout Ratio | -0.05% | -0.18% | -2.89% | 54.34% | -21.60% |